Lee Financial’s Pediatrix Medical MD Stock Holding History

Lee Financial’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-39	Closed	-$2K	–	509
2017 Q2	$2K	Buy	+39	New	+$2.31K	﹤0.01%	467

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Lee Financial's MD Position: Q3 2017 in Review

Lee Financial sold out of Pediatrix Medical (MD) in Q3 2017, closing a stake of 39 shares — an estimated $2K sold.

Lee Financial first reported a position in MD in Q2 2017 and held it in 1 quarter. The position peaked at $2K in Q2 2017. 337 funds tracked by Wall St. Rank hold MD as of Q3 2017.

Lee Financial reported no remaining Pediatrix Medical position as of Q3 2017 after selling out during the quarter.
Lee Financial sold 39 Pediatrix Medical shares in Q3 2017, an estimated $2K.
Lee Financial first reported a position in Pediatrix Medical in Q2 2017 and held it in 1 quarter.
Lee Financial's Pediatrix Medical position peaked at $2K in Q2 2017.
337 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2017.

Based on Lee Financial's 13F filing for Q3 2017, filed 7 Nov 2017.